NCT07018427 2025-06-12Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast CancerPeking University Cancer Hospital & InstituteActive not recruiting70 enrolled